Nia Impact Advisors, LLC Invitae Corp Transaction History

Nia Impact Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$1.2 - $2.73 $7,636 - $17,373	-6,364 Reduced 37.73%	10,505 $14,000
Q4 2022 Feb 09, 2023	SELL	$1.71 - $3.61 $20,865 - $44,049	-12,202 Reduced 41.97%	16,869 $31,000
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $179,301 - $814,404	-94,369 Reduced 76.45%	29,071 $72,000
Q2 2022 Aug 05, 2022	SELL	$2.13 - $9.01 $147,183 - $622,591	-69,100 Reduced 35.89%	123,440 $301,000
Q1 2022 May 11, 2022	BUY	$6.28 - $15.59 $404,281 - $1 Million	64,376 Added 50.23%	192,540 $1.54 Million

Q4 2021 Feb 11, 2022	BUY	$14.7 - $28.67 $270,244 - $527,069	18,384 Added 16.75%	128,164 $1.43 Million
Q3 2021 Nov 16, 2021	BUY	$24.31 - $33.6 $2.67 Million - $3.69 Million	109,780 New	109,780 $3.12 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Nia Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nia Impact Advisors, LLC with notifications on news.